Ipamorelin is a synthetic peptide classified as a growth hormone secretagogue, developed for research into growth hormone regulation, metabolic function, and physiological performance. It is known for its selective stimulation of growth hormone release by mimicking the action of ghrelin without significantly affecting other hormones. In experimental settings, Ipamorelin is studied for its potential to support growth hormone and insulin-like growth factor-1 (IGF-1) pathways, which may influence metabolism, recovery, and body composition. Its selective mechanism makes it a valuable compound in research focused on controlled hormone modulation. Ipamorelin is also of interest in studies related to fat metabolism, recovery processes, and overall endocrine system function, making it a widely researched peptide in laboratory environments.